LungLife AI shares up 42% after successful validation of cancer diagnostic test
Shares jump 42% on positive trial resultsCancer prediction 81% compared with 60% for standard careDiagnosing lung cancer early is critical for patientsShares in LungLife AI (LLAI:AIM), the developer of clinical diagnostic solutions...
02 January 2024